CKW Financial Group’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-700
| Closed | -$46K | – | 197 |
|
|
2024
Q4 | $46K | Hold |
700
| – | – | 0.01% | 137 |
|
|
2024
Q3 | $49K | Hold |
700
| – | – | 0.01% | 138 |
|
|
2024
Q2 | $57K | Hold |
700
| – | – | 0.01% | 127 |
|
|
2024
Q1 | $61K | Hold |
700
| – | – | 0.01% | 126 |
|
|
2023
Q4 | $67K | Hold |
700
| – | – | 0.01% | 121 |
|
|
2023
Q3 | $62K | Hold |
700
| – | – | 0.01% | 116 |
|
|
2023
Q2 | $61K | Hold |
700
| – | – | 0.01% | 117 |
|
|
2023
Q1 | $68K | Hold |
700
| – | – | 0.01% | 101 |
|
|
2022
Q4 | $72K | Sell |
700
-100
| -13% | -$10.3K | 0.01% | 87 |
|
|
2022
Q3 | $68K | Hold |
800
| – | – | 0.01% | 93 |
|
|
2022
Q2 | $68K | Hold |
800
| – | – | 0.01% | 96 |
|
|
2022
Q1 | $63K | Buy |
800
+150
| +23% | +$11.8K | 0.01% | 115 |
|
|
2021
Q4 | $60K | Hold |
650
| – | – | 0.01% | 112 |
|
|
2021
Q3 | $50K | Hold |
650
| – | – | 0.01% | 120 |
|
|
2021
Q2 | $55K | Buy |
650
+200
| +44% | +$16.9K | 0.01% | 115 |
|
|
2021
Q1 | $34K | Hold |
450
| – | – | 0.01% | 124 |
|
|
2020
Q4 | $39K | Buy |
450
+200
| +80% | +$17.3K | 0.01% | 113 |
|
|
2020
Q3 | $19K | Hold |
250
| – | – | ﹤0.01% | 126 |
|
|
2020
Q2 | $31K | Hold |
250
| – | – | 0.01% | 108 |
|
|
2020
Q1 | $21K | Buy |
+250
| New | +$21K | 0.01% | 114 |
|
|
2015
Q3 | – | Sell |
-140
| Closed | -$19K | – | 177 |
|
|
2015
Q2 | $19K | Hold |
140
| – | – | 0.01% | 219 |
|
|
2015
Q1 | $17K | Hold |
140
| – | – | 0.01% | 237 |
|
|
2014
Q4 | $13K | Buy |
+140
| New | +$13K | 0.01% | 261 |
|